The pharmaceutical industry is navigating one of its most disruptive periods in recent memory, according to Anthony Lakavage, ...
This guide explores how capsule counting machines work, why they matter, and what to consider when choosing one for your ...
New US pharmaceutical tariffs reach up to 100%, with exemptions for companies that strike pricing deals or commit to domestic manufacturing.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The European health technology ...
DAVIS, Calif.--(BUSINESS WIRE)--Botanical Solution, a leading producer of advanced botanical materials, has won two awards in the 2024 Pharmaceutical Technology Excellence Awards in the Innovation and ...
DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
Hosted on MSN
Building AGI for the pharmaceutical industry, Deep Intelligent Pharma secures another US$60 million in funding
AI pharmaceutical-development unicorn Deep Intelligent Pharma has recently completed a new financing round of US$60 million. New investors in this round include Trustar Capital, Jinyi Capital, and ...
Integrating high-throughput proteomics into pharmaceutical R&D has shifted how laboratories approach target identification and disease modeling. Mapping complex protein networks provides a functional ...
Henan Medinno Pharmaceutical Technology Co. Ltd. has synthesized TGF-β receptor type-1 (TGFBR1; ALK5; SKR4; TβR-I) inhibitors reported to be useful for the treatment of cancer, aging, arteriosclerosis ...
Royalty Rates in Pharmaceutical and Biotechnology Deals 2010-2025- Product Image Royalty Rates in Pharmaceutical and Biotechnology Deals · GlobeNewswire Inc. Royalty Rates in Pharmaceutical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results